DROOLING

Clinical trials for DROOLING explained in plain language.

Never miss a new study

Get alerted when new DROOLING trials appear

Sign up with your email to follow new studies for DROOLING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

New injection may curb drooling in Parkinson's patients

Symptom relief Completed

This study tested whether injections of Myobloc (botulinum toxin type B) into the salivary glands can safely reduce drooling in people with Parkinson's disease. Fifty-four participants received either Myobloc or a placebo. The main goal was to see if drooling severity and frequen…

Matched conditions: DROOLING

Phase: PHASE2 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC • Aim: Symptom relief

Last updated Jun 27, 2026 12:23 UTC

DROOLING

Get alerted when new DROOLING trials appear

New injection may curb drooling in Parkinson's patients